Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 1982HypertensionOpen Access

Attenuation of pressor responses to norepinephrine and pitressin and potentiation of pressor response to angiotensin II by captopril in human subjects.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does captopril alter the pressor responses to norepinephrine, angiotensin II, and pitressin in normal male volunteers?

Population

38 normal male volunteers aged 20 to 35 years

Comparison

Captopril 50 mg by mouth vs Baseline responses before captopril treatment

Design

Other

Follow-up

10 minutes per infusion

Authors

YIYutaka ImaiUniversity College DublinKAK AbeMSMASAHIDE SEINOHenry Ford Health System

Discussion

Loading...

Member takes

Implication

Does not support practice change in hypertension; leaves open translation of vasopressor interactions to patients.

Key Points

  • The study aims to understand how captopril influences blood pressure responses to various vasopressor substances in healthy individuals.
  • Involved 38 normal male volunteers, ages 20-35 years.
  • Infused norepinephrine, angiotensin II, and pitressin to assess pressor responses.
  • Evaluated responses both before and after administering captopril orally.
  • Captopril significantly reduced pressor responses to norepinephrine and pitressin.
  • Captopril enhanced the pressor response to angiotensin II, indicating a complex interaction.
  • Subdepressor doses of angiotensin II negated the effects of captopril on pressor response to norepinephrine.

Structured PICO

Does captopril alter the pressor responses to norepinephrine, angiotensin II, and pitressin in normal male volunteers?

P
Population
38 normal male volunteers aged 20 to 35 years
I
Intervention
Captopril 50 mg by mouth
C
Comparator
Baseline responses before captopril treatment
O
Outcome
Pressor responses to exogenously administered norepinephrine, angiotensin II, and pitressinsurrogate

Captopril attenuates pressor responses to norepinephrine and pitressin primarily by depleting endogenous angiotensin II, which may desensitize arterial smooth muscle contraction.

Cite This Study

Imai et al. (1982) studied this question.

synapsesocial.com/papers/6a70c811a528af2d65c3bb82https://doi.org/10.1161/01.hyp.4.3.444
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The effect of captopril on heart rate in several types of hypertensive patients.1981 · 6 citations
  2. 2Pressor Responsiveness to Angiotensin in Renovascular and Steroid Hypertension1979 · 4 citations
  3. 3General Circulatory Alterations Induced by Intravenous Infusion of Synthetic Bradykinin in Man1964 · 79 citations
  4. 4Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients1979 · 356 citations
  5. 5Does captopril lower blood pressure in anephric patients?1979 · 28 citations